NCT02332096View on ClinicalTrials.gov

Screening for Sleep Apnea in Patients Undergoing Atrial Fibrillation Ablation

CompletedOBSERVATIONAL
Enrollment

130

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

February 7, 2020

Study Completion Date

February 7, 2020

Conditions
Atrial FibrillationObstructive Sleep ApneaCardiac Arrhythmias
Interventions
DEVICE

Home Sleep Testing Device

Patients will undergo obstructive sleep apnea screening with a FDA approved home sleep testing device.

Trial Locations (1)

02215

Beth Israel Deaconess Medical Center, Boston

All Listed Sponsors
lead

Beth Israel Deaconess Medical Center

OTHER

NCT02332096 - Screening for Sleep Apnea in Patients Undergoing Atrial Fibrillation Ablation | Biotech Hunter | Biotech Hunter